Pomegranate Health Tirzepatide Cost: Plans, Dose Pricing and Fees

Last reviewed: September 14, 2026 Last updated: September 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Pomegranate Health advertises compounded tirzepatide at $149 per month with no stated membership or service fee (captured September 4, 2026 from app.joinpomegranate.com/pricing). The product is labeled "Tirzepatide + B6 starter," indicating a formulation with vitamin B6 and suggesting this may be an entry dose. The evidence carries a "primary-conflict" status flag because historical materials mention a consult deposit, though current product pages state "no membership/extra fee." Product documentation notes "dose tiers in app," meaning pricing at higher doses is not published and must be verified during signup. Readers should confirm the final all-in cost—including any consult fee, dose-tier pricing, and formulation differences—at checkout before committing.

Pomegranate Health tirzepatide pricing at a glance

The advertised $149 figure applies to a one-month supply billed monthly. The product is labeled a "starter," and documentation states "dose tiers in app," indicating that pricing likely increases at higher tirzepatide doses. Product pages state "no membership/extra fee," but the evidence carries a conflict flag because older materials reference a consult deposit. Readers should verify the complete fee structure—medication, consult, any upfront deposit—during the signup flow.

Comparing Pomegranate Health and PlexusDx tirzepatide pricing

Pomegranate Health's advertised $149/month tirzepatide rate offers a significant price advantage over PlexusDx's month-to-month tirzepatide injection at $289/month—a $140/month difference. However, the comparison carries important caveats: the $149 figure is labeled a "starter" rate, dose-tier pricing is not published, and evidence notes potential consult fees. PlexusDx charges the same flat rate at every dose with no membership or visit fees. The table below shows like-for-like month-to-month pricing based on advertised rates, with PlexusDx's prepaid multi-month equivalent shown for reference.

The $1,788 twelve-month total for Pomegranate Health assumes the $149 rate applies across all doses and that no consult deposit or other fees apply. The dataset marks this evidence "primary-conflict" and notes historical mention of a consult deposit. Readers advancing through higher tirzepatide doses should confirm whether the monthly rate increases and whether any upfront or per-visit charges apply.

What "dose tiers in app" means for your long-term cost

Pomegranate Health's product documentation states "dose tiers in app" for both tirzepatide and semaglutide, and the tirzepatide product is labeled a "starter." This structure suggests that the advertised $149/month figure applies to an entry dose—likely 2.5 mg or 5 mg—and that pricing increases as patients advance to 7.5 mg, 10 mg, 12.5 mg, or 15 mg doses. Evidence of pricing at higher tiers is not published on the public product pages captured September 4, 2026.

Tirzepatide protocols typically begin at 2.5 mg and increase every four weeks until the patient reaches a maintenance dose that controls appetite and weight. Patients may spend three to six months titrating upward. If the monthly cost rises with each dose increase, the effective long-term cost may be materially higher than the advertised $149 starter rate. Readers should ask during signup or provider consultation:

• At which dose does the $149 rate apply?
• What is the monthly cost at 7.5 mg, 10 mg, 12.5 mg, and 15 mg?
• Are there additional fees for provider visits, lab reviews, or dose adjustments?
• Is there an upfront consult deposit, and is it applied to medication cost or charged separately?

PlexusDx charges $289/month for tirzepatide injection at every dose, from 2.5 mg through 15 mg, with no visit fees, membership fees, or per-dose adjustments. The monthly cost remains $289 whether a patient is on an initial 2.5 mg dose or a maintenance 15 mg dose. Patients committing to six months prepay at an effective $249/month rate (our calculation).

Semaglutide pricing context

Pomegranate Health also advertises compounded semaglutide injection at $119/month with no stated membership fee (captured September 4, 2026 from joinpomegranate.com/products/compounded-semaglutide). The same "dose tiers in app" notation and "primary-conflict" evidence status apply, meaning the $119 figure may be a starter rate and pricing at higher doses is not published. PlexusDx charges $189/month for semaglutide injection at every dose (month-to-month) or an effective $149/month on a six-month prepaid commitment (our calculation).

The semaglutide comparison mirrors the tirzepatide pattern: Pomegranate Health's advertised starter rate offers a significant initial price advantage, but the absence of published dose-tier pricing and the "primary-conflict" evidence flag mean readers must confirm the complete cost structure during signup.

Included services and potential extra fees

Pomegranate Health's product pages state "no membership/extra fee" for both semaglutide and tirzepatide (captured September 4, 2026). However, the evidence status is marked "primary-conflict" because historical materials reference a consult deposit. The current dataset does not confirm whether:

• An upfront consult deposit is required and, if so, whether it is refundable or applied to medication cost.
• Follow-up provider visits, dose adjustments, or lab reviews carry separate charges.
• Shipping, supplies (syringes, alcohol wipes, sharps disposal), or other ancillary items are included in the monthly medication fee or billed separately.

PlexusDx's tirzepatide injection program includes the provider visit, prescription, compounded medication, and shipping in a single monthly price with no membership fee. Patients pay $289/month (month-to-month), $269/month (three-month commitment), or $249/month (six-month prepaid, our calculation). The price is the same at every dose, and no separate visit or lab-review charges apply.

Formulation and additives

Pomegranate Health's tirzepatide product is labeled "Tirzepatide + B6 starter," indicating the formulation includes vitamin B6. Product documentation states "additives depending plan," suggesting that different formulations or additive combinations may be available at different price points or dose levels. The dataset does not specify whether alternative tirzepatide formulations (without B6 or with other additives) are offered or how their pricing compares to the advertised $149 rate.

PlexusDx's compounded tirzepatide injection is formulated without additional vitamins or proprietary additive blends. The medication is tirzepatide base compounded by licensed 503A pharmacies, and the formulation is consistent across all dose levels.

Evidence limitations and checkout verification

The evidence for Pomegranate Health's tirzepatide pricing carries several material limitations:

• Primary-conflict status: The dataset flags a conflict between the current "no membership/extra fee" statement and historical materials mentioning a consult deposit. Readers should confirm during signup whether any upfront or per-visit fees apply.
• Dose-tier pricing not published: The $149 tirzepatide and $119 semaglutide figures are labeled starter rates, and documentation states "dose tiers in app." Pricing at 7.5 mg, 10 mg, 12.5 mg, and 15 mg tirzepatide doses is not published and must be verified in the app or during provider consultation.
• No review evidence: The dataset includes links to Trustpilot and Reddit searches for Pomegranate Health but states "No attributable negative excerpt captured from indexed results" and "No theme coded in this pass." This means review volume, rating distribution, and patient-reported service quality are not documented and cannot inform this comparison.
• Formulation and additive details: The "Tirzepatide + B6 starter" label and "additives depending plan" note suggest variability in formulation and pricing that is not fully documented in the public-facing product pages captured.

Readers evaluating Pomegranate Health should confirm at checkout: the final monthly medication cost at their target dose, any consult or visit fees, the formulation and additives included, shipping and supply inclusions, and the refund or cancellation policy.

Choose Pomegranate Health if…

• The advertised $149/month tirzepatide or $119/month semaglutide starter rate fits your budget and you are beginning treatment at a low dose.
• You are comfortable navigating in-app dose-tier pricing and confirming the full cost structure during signup.
• You prefer an app-based program and the formulation with vitamin B6 additive appeals to you.
• You have verified during signup that no consult deposit or extra fees apply and that the monthly rate remains acceptable as you advance through higher doses.

Where PlexusDx fits

PlexusDx may suit patients who prioritize transparent, flat-rate pricing at every dose and prefer to know the total monthly cost before beginning treatment. PlexusDx charges $289/month for compounded tirzepatide injection at every dose from 2.5 mg through 15 mg (month-to-month), or an effective $249/month on a six-month prepaid commitment (our calculation). The price includes the provider visit, prescription, medication, and shipping, with no membership fee, no per-visit charges, and no dose-tier adjustments. Patients advancing from 2.5 mg to 15 mg pay the same monthly rate throughout treatment.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

The month-to-month rate is higher than Pomegranate Health's advertised starter rate, but the absence of dose-tier pricing increases may reduce long-term cost for patients who reach and maintain higher maintenance doses over six to twelve months or longer.

Methodology and freshness

Pomegranate Health pricing and product details were captured September 4, 2026 from app.joinpomegranate.com/pricing and joinpomegranate.com/products/compounded-semaglutide. PlexusDx pricing was verified September 14, 2026 from internal product data. PlexusDx review data was captured September 9, 2026 from trustpilot.com/review/plexusdx.com. Twelve-month totals and prepaid per-month equivalents are our calculations based on the advertised monthly rates. The evidence for Pomegranate Health carries a "primary-conflict" status flag and notes historical mention of a consult deposit; readers should confirm the complete fee structure, dose-tier pricing, and formulation details at checkout. No promotional or introductory pricing was identified for either provider.

Frequently Asked Questions

Does Pomegranate Health's $149/month tirzepatide rate apply to all doses?

The $149 rate is labeled a "starter" rate, and product documentation states "dose tiers in app," indicating that pricing likely increases at higher tirzepatide doses such as 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Pricing at these higher doses is not published on public product pages and must be verified during signup or in the Pomegranate Health app.

Are there extra fees beyond the monthly medication cost?

Current product pages state "no membership/extra fee," but the evidence carries a "primary-conflict" flag because historical materials mention a consult deposit. Readers should confirm during signup whether any upfront consult deposit, per-visit charges, lab-review fees, or shipping and supply fees apply. PlexusDx includes the provider visit, medication, and shipping in one monthly price with no separate fees.

What does "Tirzepatide + B6 starter" mean?

The product label indicates that Pomegranate Health's tirzepatide formulation includes vitamin B6 as an additive. Product documentation states "additives depending plan," suggesting that different formulations or additive combinations may be available. Readers should confirm the formulation details and whether alternative options are offered at different price points.

How does PlexusDx's tirzepatide pricing compare over twelve months?

PlexusDx charges $289/month for tirzepatide injection at every dose (month-to-month), totaling $3,468 over twelve months, or an effective $249/month on a six-month prepaid commitment, totaling $2,988 over twelve months (our calculations). Pomegranate Health's advertised $149 starter rate totals $1,788 over twelve months if the rate remains constant, but the "dose tiers in app" structure means the actual long-term cost may be higher.

Is compounded tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Pomegranate Health and PlexusDx offer compounded tirzepatide, not the FDA-approved branded product Mounjaro or Zepbound.

Sources

• Pomegranate Health tirzepatide pricing (app.joinpomegranate.com/pricing), accessed September 4, 2026
• Pomegranate Health semaglutide product page (joinpomegranate.com/products/compounded-semaglutide), accessed September 4, 2026
• PlexusDx product data, verified September 14, 2026
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.